---  
layout: startup_page  
title: "TRex Bio"  
id: "trex.bio"  
permalink: "/trexbiotrex.bio11132024/"  
website: "https://trex.bio/"  
funding_round: "Series B"  
funding_amount: "$84M"  
investors: "Delos Capital, Avego BioScience Capital, Agent Capital, Eli Lilly and Company, SV Health Investors, Pfizer Ventures, Johnson & Johnson, Alexandria Venture Investments, Polaris Partners"  
about: "TRexBio is a biotechnology company focused on developing revolutionary therapeutics by decoding human tissue immune biology. They utilize a proprietary platform to map Treg behavior and identify novel targets for therapeutic intervention, creating a broad portfolio of therapies that modulate the immune system to restore immune homeostasis. Their lead candidate, TRB-061, is designed to selectively activate tissue-licensed Tregs to address inflammatory and autoimmune conditions."  
markets: "Biotechnology, Immunology, Therapeutics, Bioinformatics, Biopharma"  
hq: "South San Francisco, California, United States"  
founded_year: "2018"  
linkedin: "https://www.linkedin.com/company/trexbio-inc"  
twitter: ""  
instagram: ""  
facebook: ""  
crunchbase: "https://www.crunchbase.com/organization/trex-bio"  
pitchbook: "https://pitchbook.com/profiles/company/230495-68"  

date_display: "13-Nov-2024"  
date: "2024-11-13"

# SEO Optimization  
meta_title: "TRex Bio - Series B Funding ($84M)"  
meta_description: "TRex Bio, TRexBio is a biotechnology company focused on developing revolutionary therapeutics by decoding human tissue immune biology. They utilize a proprietar..."  
meta_keywords: "TRex Bio, Biotechnology, Immunology, Therapeutics, Bioinformatics, Biopharma, Series B funding"  
canonical_url: "https://startup.projectstartups.com/trexbiotrex.bio11132024/"  
---